- Home
- BMRA vs MIRA Comparison
BMRA vs MIRA Comparison
Compare BMRA & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- MIRA
- Stock Information
- Founded
- BMRA 1971
- MIRA 2020
- Country
- BMRA United States
- MIRA United States
- Employees
- BMRA N/A
- MIRA N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- MIRA Health Care
- Exchange
- BMRA Nasdaq
- MIRA Nasdaq
- Market Cap
- BMRA 8.2M
- MIRA 26.5M
- IPO Year
- BMRA N/A
- MIRA 2023
- Fundamental
- Price
- BMRA $2.92
- MIRA $1.29
- Analyst Decision
- BMRA
- MIRA Strong Buy
- Analyst Count
- BMRA 0
- MIRA 1
- Target Price
- BMRA N/A
- MIRA $17.00
- AVG Volume (30 Days)
- BMRA 425.8K
- MIRA 804.3K
- Earning Date
- BMRA 10-14-2025
- MIRA 11-11-2025
- Dividend Yield
- BMRA N/A
- MIRA N/A
- EPS Growth
- BMRA N/A
- MIRA N/A
- EPS
- BMRA N/A
- MIRA N/A
- Revenue
- BMRA $5,311,000.00
- MIRA N/A
- Revenue This Year
- BMRA N/A
- MIRA N/A
- Revenue Next Year
- BMRA N/A
- MIRA N/A
- P/E Ratio
- BMRA N/A
- MIRA N/A
- Revenue Growth
- BMRA N/A
- MIRA N/A
- 52 Week Low
- BMRA $2.08
- MIRA $0.73
- 52 Week High
- BMRA $10.16
- MIRA $2.56
- Technical
- Relative Strength Index (RSI)
- BMRA 43.27
- MIRA 40.50
- Support Level
- BMRA $2.87
- MIRA $1.19
- Resistance Level
- BMRA $3.08
- MIRA $1.72
- Average True Range (ATR)
- BMRA 0.21
- MIRA 0.10
- MACD
- BMRA 0.01
- MIRA -0.01
- Stochastic Oscillator
- BMRA 54.93
- MIRA 18.25
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.